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Abstract
The last decade has seen the evaluation of health research pay more and more attention to societal use and bene-
fits of research in addition to scientific quality, both in qualitative and quantitative ways. This paper elaborates pri-
marily on a quantitative approach to assess societal output and use of research performed by health research
groups (societal quality of research). For this reason, one of the Dutch university medical centres (i.e. the Leiden
University Medical Center (LUMC)) was chosen as the subject of a pilot study, because of its mission to integrate
top patient care with medical, biomedical and healthcare research and education. All research departments were
used as units of evaluation within this university medical centre.
The method consisted of a four-step process to reach a societal quality score per department, based on its
(research) outreach to relevant societal stakeholders (the general public, healthcare professionals and the private
sector). For each of these three types of stakeholders, indicators within four modes of communication were
defined (knowledge production, knowledge exchange, knowledge use and earning capacity). These indicators were
measured by a bottom-up approach in a qualitative way (i.e. all departments of the LUMC were asked to list all
activities they would consider to be of societal relevance), after which they were converted into quantitative
scores. These quantitative scores could then be compared to standardised scientific quality scores that are based
on scientific publications and citations of peer-reviewed articles.
Based on the LUMC pilot study, only a weak correlation was found between societal and scientific quality. This
suggests that societal quality needs additional activities to be performed by health research groups and is not sim-
ply the consequence of high scientific quality. Therefore we conclude that scientific and societal evaluation should
be considered to be synergistic in terms of learning for the future, accountability and advocacy.
This quantitative approach to assess societal quality in a quantitative sense is based on indicators that function as
proxies for society quality on different levels, based on the communication of researchers with their societal stake-
holders (i.e. knowledge production, knowledge exchange and knowledge use). The methodology presented is just
a first attempt to compare scientific quality scores (publication and citation scores) with societal quality scores in a
quantitative way. This comparison can be used by organisations (e.g. university medical centres) in their planning
and control cycle.
Introduction
Research evaluation is meant to learn from, to account
for and to advocate research performance [1-3].
Research evaluation developed in the last fifty years
from measuring resources (inputs), policy and manage-
ment (throughputs) and products (outputs) [4]. Also
scientific use (scientific references) [3,5] and benefits of
research results in the research community were
included [6,7]. It is from the 1990s that societal pro-
ducts (outputs) [8-10], societal use (societal references)
and societal benefits (changes in society) also came into
scope [11-21].
This study was set up within a Dutch university medi-
cal centre: the Leiden University Medical Center
(LUMC). University medical centres in the Netherlands
are the result of mergers between university hospitals
and medical faculties of universities, and combine uni-
versity patient care with medical, biomedical and health-
care research and the education and training of doctors,
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study was limited to research group evaluation. A
research group is the minimal unit responsible for the
scientific process as a whole: its resources, its direction
and focus (policy), its organisation (management), its
productivity and its impact on science and society. The
study further focuses on societal outputs and use (socie-
tal quality) as an addition to scientific outputs and use
(scientific quality). The study concentrates on transver-
sal evaluation of research group performance rather
than longitudinal evaluation of the research itself. Real
societal impact (i.e. the increased state of public health)
was not included in this study because it is virtually
impossible to attribute public health changes to just one
research group in the relatively short time frame of a
transversal evaluation [22].
Research aims at the production of new knowledge
and new skills that can be used in society [23-25].
Therefore, new knowledge is taught to students, is writ-
ten down in scientific publications (formal knowledge)
and professionals are trained with new skills (tacit
knowledge). Research has both short-term (applied
r e s e a r c h )a sw e l la sl o n g - t e r mp r a c t i c a lo b j e c t i v e s( b a s i c
research). In general, basic research is considered to be
an important source of new ideas (leads) for applied
research, which in turn creates the societal basis for
basic research [26-28]. This notion is effectively
exploited by medical charities [29,30]. In health research
this might be obvious, however until recently it has not
been translated into evaluation practice [31]. Medical
faculties devoted to basic research were evaluated on
the basis of the scientific value of their research and the
societal value of their teaching. Academic hospitals were
evaluated on their innovative health care performance
and their medical speciality training.
This situation has changed dramatically in the
Netherlands over the last decade once all eight medical
faculties merged with their local academic hospitals into
eight University Medical Centers (UMCs). In addition,
the medical research department of the Dutch Research
Council (NWO-MW), which was mainly devoted to
basic medical research, merged with the research orga-
nisation (ZON) of the Ministry of Health, Welfare and
Sport, which was more focussed on health care research
and innovation. The resulting organisation, ZonMw
(Netherlands Organisation for Health Research & Devel-
opment) is now the health component of the science
system as well as the R&D component of the public
health (innovation) system. As such, science and innova-
tion systems for medical and health research have now
effectively become integrated in the Netherlands.
The ultimate objective of health research is to improve
the health outcome of each individual [32,33]. Accord-
ing to the Council for Medical Sciences of the Royal
Netherlands Academy of Arts and Sciences (KNAW),
health research has a dual mission, namely a scientific
and a societal one: “it is explicitly concerned not only
with the acquisition of scientific knowledge as such, but
also with the usefulness and implementation of scientific
achievements” [14]. The interaction of health research
with society (health care, health industry and the general
public) needs to be intensified, in order to accelerate
and enhance effectiveness of the health innovation sys-
tem and to enhance public support for health research.
Despite the societal character of health research, the
performance of (bio)medical researchers still tends to be
measured by the scientific quality of their research
rather than by its use by the health care sector and its
benefits to society at large. The funding agencies of
health research in the Netherlands, the UMCs, the
research organisations and individual researchers all
strive for high scientific and societal quality, but current
systems for evaluating the performance of research still
focus on scientific quality. In 2001, the KNAW stated
that “a new evaluation instrument is needed for measur-
ing societal quality” [14]. Both quantitative and qualita-
tive approaches to research evaluation can be used to
connect the aims of health research to its perceived
value of research outcomes, whether this is tied to
scientific excellence or usefulness. In view of the tension
between quantitative metrics being seemingly objective
and external peer review being possibly subjective, a
middle ground where quantitative quality measures are
supported by peer review and vice versa should be
sought for so that the strengths of each approach may
compensate for the limitations of the other [19,34,35].
In recent years, a limited number of methods, indica-
tors and criteria to assess the societal quality of funda-
mental, strategic and applied research have been
developed. One method is the Sci_Quest method [36]
that investigates the relationships between a research
institute and its relevant context such as society, policy,
and industry (stakeholders), which is applicable to all
research domains. Another method is the Payback fra-
mework for assessing the impacts of health (care)
research, which consists of a multidimensional categori-
sation of benefits and a model of how to assess them
[37,30,38]. The Payback framework has been applied in
the evaluation of the Health Care Efficiency Research
programme of ZonMw [39]. In both 2007 and 2009, an
international workshop was organised by the Swedish
Research Council to discuss the concept of evaluation of
socio-economic impacts from medical/health research.
Recently an international and interdisciplinary consor-
tium (SIAMPI) of knowledge institutions supported by
the European Commission (within the Seventh Frame-
work Programme) was created with the aim of develop-
ing methods for the assessment of social quality of
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context of the Dutch culture favouring outcome metrics,
and the search for simplicity in research assessment, the
methodology presented here builds on metrics first,
while acknowledging that qualitative procedures need to
be added in order to eventually reach an intelligent and
advanced combined system of health research
evaluation.
Methodology
A first attempt to describe how to assess and compare
scientific and societal quality of (health) research within
one integrated framework was published by Van Ark
and Klasen in 2007 [22]. In 2007, the framework was
put into practice in a pilot study within the LUMC. The
pilot study met the objective of the Executive Board to
make the societal profile of the LUMC explicit in accor-
dance to its mission statement.
The framework of Van Ark and Klasen is based on the
concept of communication. In communication theory
target groups and modes of communication are differen-
tiated [7]. In that view, the outputs of a research groups
depend on the quality and quantity of the communica-
tion (outreach) with relevant target sectors. Therefore,
scientific quality essentially depends on the communica-
tion with the scientific community and societal quality
depends on the communication with different societal
sectors. Even though the interaction between science
and society is increasing, it is often realised at the level
of research programming, rather than at the level of
research execution.
We define three types of societal sectors (or stake-
holders): the general (lay) public, healthcare profes-
sionals and the private sector. In these sectors
respectively cultural, social and economic outputs of
research will appear. In health research, the general pub-
lic is represented by the (mass) media. Healthcare pro-
fessionals represent the healthcare system itself,
including public health, health policy and health insur-
ance systems. The private sector mainly consists of the
human pharmaceutical and biotechnological, the medi-
cal ICT, medical devices and medical services sectors.
As modes of communication we use the same cate-
gories for both scientific and societal quality: knowledge
production, knowledge exchange, knowledge use and
earning capacity. Knowledge production is presented in a
communicable form such as publications in all kind of
media (scientific, professional or lay literature, radio,
TV, papers, internet), services and/or products. Commu-
nication can also be in the form of direct knowledge
exchange such as lectures and courses (from sender to
receiver), conferences and external participation in
research (group) guidance and governance (mutual
interaction) and/or recognitions of repute (from receiver
to sender) such as invited lectures and courses, awards,
prizes and invited functions of researchers in external
bodies. When knowledge products are transferred effec-
tively to the stakeholders, knowledge use can arise as
external citation of publications in the media mentioned,
the external purchase and returns on products and ser-
vices delivered. As an expression of the external value of
a research group, the attraction of external resources or
funds can be used: e.g. charity funding as a measure of
perceived quality by the general public, research council
and European funding as a measure of healthcare pro-
fessional quality and private funding as a measure of
quality for the private sector. Therefore the magnitude
of the earning capacity shows to what extent the societal
stakeholders are willing to contribute to the research
[22]. While research income is often used as a proxy for
research excellence, here we consider it as linking socie-
tal quality to scientific merit.
Benefits such as a contribution to the knowledge base
in medicine (scientific), improvements in public health
(social), prosperity (private) and public understanding
(cultural) tend to take decades to develop and are vir-
tually impossible to attribute to a single research group
only [40,41]. Therefore, we have left scientific and socie-
tal impact of research (groups) out of the scope of this
study as mentioned before, and discuss the level of soci-
etal outputs as a measure for societal quality only. How-
ever, we anticipate that in order to create societal
impact, societal outputs are a sine qua non.
The pilot study followed a step-by-step procedure. It
was set up so as to reach a good understanding of the
concept of societal evaluation in addition to scientific
evaluation in the near future, to explain the purpose of
the pilot study to internal and external stakeholders and
to aim for proper participation. The first stage consisted
of a thorough inventory of two research groups with a
good understanding of societal evaluation and willing-
ness to participate in the pilot. These research groups
were asked to deliver all kinds of information that they
judged to be relevant. The data received was used to
guide the second stage: an inventory of 43 departments,
reflecting all research groups of the LUMC. An intro-
ductory letter from the Executive Board accompanied
the voluntary inventory, to explain the scope and pur-
pose of the pilot study and to ask for cooperation. The
inventory was semi-structured consisting of two parts.
In the predefined part, societal outreach data could be
introduced in terms of indicators for societal knowledge
production, knowledge exchange and knowledge use. In
the open part, societal quality related data that the parti-
cipants found to be relevant but which were not repre-
sented in the predefined part could be introduced and
clarified. The response rate was 19/43 (45%) of the
departments, representing approximately 60% of the
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existing data on scientific quality (produced for many
years by the Centre for Science and Technology Studies
(CWTS) and accepted by the departments) and earning
capacity were added from the administrative database.
In the third and final analysis stage, all data was
lumped into 23 indicator categories. Per indicator cate-
gory, an adjustable weighting factor was introduced in
order to differentiate between the importance of the
chosen indicators. It was then possible to enter the 23
indicator categories into a 12-cell matrix consisting of 3
columns representing the target sectors and 4 rows
representing the modes of communication (see Table 1).
Results
This section deals with a description of the procedure
undertaken in order to acquire and quantify the societal
outreach of the departments. In addition to this descrip-
tion, the validation of the methodology used and its uti-
lity for institutional policy are taken into consideration.
Data acquisition and quantification
All reported societal outreach was categorised and
counted per department. Here we describe the use of
weighting factors to adjust the importance of the indica-
tors that are used, and the way to quantify the obtained
qualitative dataset. The calculation of the quantitative soci-
etal quality score consists of four discrete steps, which will
be explained below. The 23 (bottom up) categories are
considered to be suitable indicators (see Table 1).
Step 1 - Indicator occurrences
In order to be able to compare the results of the LUMC
departments mutually, the number of occurrences of
each indicator (e.g. the number of contributions to tele-
vision programmes, the number of contributions to
medical charters or protocols or the number of patents)
for every single department is related to the average
number of occurrences of that indicator for all the
departments.
Step 2 - Weighting system
When the number of occurrences of the indicators is
related to the average of all the departments, the next step
is to calculate the weighting factor for each indicator. The
advantage of our method is that the indicators can be
weighted differently, dependent of the objectives of the
research group. To include a weighting system, first a
weighting score has to be calculated. For each sector (the
general public, healthcare professionals and the private
sector), an analysis is made of how indicator A ranks in
relation to indicators B, C, D, and so on. In this way it is
possible to calculate a relative weighting score for each
indicator (within each sector), i.e. whether the indicator is
more or less important than the other indicators.
The relative weighting score is the input for the calcu-
lation of the real weighting factor that indicates the
influence of a certain indicator compared to the others.
In addition to the option to give some indicators a
higher weighting factor, it is also possible to include
weighting factors between the three sectors to adjust for
the importance of a particular sector. In this pilot study,
the authors have defined the weighting factors. In future
iterations the weighting factors can be defined by
research groups themselves or the Executive Board.
Step 3 - Societal quality per indicator
After the creation of the weighting system, the actual
calculation of the societal quality per indicator can be
conducted. Per department and for each indicator this
specific societal quality is the result of step 1 (the rela-
tive occurrences of each indicator) and step 2 (the
weighting factor for each indicator). Societal quality per
Table 1 Societal quality indicator matrix
General public Healthcare professionals Private sector
Knowledge
production
￿ Contributions to television programmes
￿ Contributions to radio programmes
￿ Contributions to newspapers or journals
(non peer reviewed)
￿ Contributions to public websites
￿ Contributions to publics news forums
￿ Contributions to schoolbooks or study
material
￿ Publications in medical journals (non peer
reviewed)
￿ Contributions to professional websites
￿ Contributions to medical charters or
protocols
￿ Patents
Knowledge
exchange
￿ Memberships of public funding agencies
or patient organisations
￿ Speeches for general public or
contributions to public forums
￿ Information for scholars
￿ Memberships of advisory committees or
professional associations
￿ Speeches at medical conferences
￿ Speeches for companies
￿ Cooperation with companies
Knowledge
use
￿ Use of schoolbooks or study material in
medical education programmes
￿ Use of new medical charters or protocols in
medical practice for diagnosis or therapy
￿ Use of technology by companies to
produce new products or therapies
Earning
capacity
￿ Charity funding (3
rd money stream) ￿ Indirect funding (2
nd money stream) ￿ Contract funding (4
th money stream)
This table lists the indicators that are used in this pilot study for each of the three target groups and modes of communication.
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objectives of a research group and can be adjusted
accordingly. Mission, objectives and, if possible, indica-
tors should relate to perceived benefit by end users.
Step 4 - Societal quality per target group and total societal
quality
Together, the 23 individual societal quality indicators
form the basis for the calculation of the societal quality
for each sector and the total societal quality. The calcu-
lation of the general public, healthcare professionals and
the private sector societal quality is essentially similar:
for all indicators in that particular sector the average of
the indicator societal qualities is taken. The total societal
quality for the departments is obtained by taking the
average of the three sectoral societal quality scores.
Because the weight of all indicators is related to the
number of occurrences (the uniqueness = step 1) as well
as a ranking of all indicators (the importance = step 2),
where the arbitrary weighting between the different sec-
tors only takes place in the last step (4), then the
robustness of the system is greatly enhanced.
The following figure (Figure 1) presents the different
steps in the process of calculating the societal quality of
a research group.
When comparing the total societal quality to the scienti-
fic quality scores of the departments, it is shown that cor-
relation between the two is weak (see Figure 2). This
suggests that high scientific quality of research groups is
not necessarily related to communication with society, and
that in order to increase societal quality of research
groups, additional activities are needed. Therefore societal
quality is not simply the consequence of high scientific
quality. Obviously, in a university medical centre, scientific
quality prevails, and is a prerequisite, which cannot be
replaced by aiming instead for high societal quality.
Because of the weighting of indicators, the method
can be adjusted to the objectives of the research group.
For example, when a research group’s objective is more
focused on communication with the private sector, the
indicators for private sector societal impact can be
valued as more important than the indicators for health-
care professionals societal quality. Therefore, through
these adjustments, the effects of the quantitative mea-
surements will reflect the objectives of the research
group on their outreach (if present). The following fig-
u r e( F i g u r e3 )p r e s e n t st h er e s u l t so ft h ep i l o ts t u d yf o r
each of the target groups. Based on this graph it can be
concluded that some departments focus more on private
rather than healthcare professionals or the general pub-
lic and the other way around.
It should be noted here that in the quantification pro-
cess, i.e. the calculation of societal quality, the size of a
research group is not included. It is anticipated that this
may influence the results, however it was left out
because in a university medical centre, the people on
the payroll of a department do not spend all of their
time on research since most departments also have to
perform education and care. In cases where it is not
possible to properly define the number of research
‘units’, calculations would be misleading.
Validation of the method
Given the lack of a gold standard, the first subjective
validation of the methodology was to see whether the
resulting sectoral societal qualities were in keeping with
the annual assessments of the Executive Board (sup-
ported by the LUMC central science committee) and
the latest (2006) external visitation on the departments
involved. This was generally the case, although occasion-
ally the score of departments deviated slightly. The
method proves that a high total societal quality score
can only be achieved if a department shows some activ-
ity in all sectors. Given that a strong push of the inter-
ests of industry and commerce should be
counterbalanced by a pull toward broader public com-
munication (and vice versa), this was deemed fair, as a
high score for total societal quality should be for those
departments that are aware of their potential role in all
sectors of society. In addition, departments that are cap-
able of attracting external money achieve high scores as
well, which reflects that they are recognised in society as
internationally leading groups in a relevant clinical field.
Secondly, the reliability of the method was tested by
changing the values of the different weighting factors.
Even rather major changes to the weighting factors did
not really change the results of the test. This is due to
the fact that a total of 23 separate indicators are corre-
l a t e dt oo n ea n o t h e r .T h i ss h o w st h a tt h ee x a c tc h o i c e
of indicators and their relative weight is somewhat irre-
levant as long as a stable quantitative scheme is chosen.
A more objective, external validation was performed
in collaboration with the Netherlands Organisation for
Health Research and Development (ZonMw). The
LUMC receives grants from ZonMw on the basis of
ex-ante assessment of their scientific quality and its
relevance for the research programme. Within ZonMw
different sub-departments fund different types of
research. We could demonstrate that departments
receiving grants primarily from the Science and Innova-
tion sub-department had a higher score on commercial
impact and that the departments primarily receiving
grants from other sub-departments had a higher score
on societal quality within the sectors general public and
healthcare professionals. This reflects the priority differ-
ences that exist between those separate sub-departments
of ZonMw. However, there is no difference in general
societal quality of the LUMC departments that receive
funding from the different ZonMw sub-departments.
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The communication metaphor has been shown to be
useful for introducing societal quality in addition to
scientific quality evaluation in an academic environment
accustomed to and convinced of the sense and
usefulness of the latter but not necessarily of the first.
Essentially, in a university medical centre scientific qual-
ity prevails, and is considered to be a prerequisite for
societal quality. Still, when comparing the total societal
quality to the scientific quality scores of the LUMC
Figure 1 Societal quality calculation steps. This figure shows schematically the subsequent steps that are required to calculate the total
societal quality score of each individual department.
Mostert et al. Health Research Policy and Systems 2010, 8:30
http://www.health-policy-systems.com/content/8/1/30
Page 6 of 10Figure 2 Total Societal Quality versus Scientific Quality. In this graph the Total Societal Quality is plotted against the Scientific Quality of all
LUMC departments that contributed to this study. The correlation between the two is weak which suggests that societal quality is not simply
the consequence of high scientific quality.
Figure 3 Total target group societal quality scores per department. The graph shows the societal quality scores per department for each of
the three target groups (i.e. the general public, healthcare professionals and the private sector).
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two is weak. This suggests that societal quality needs
additional activities and is not simply the consequence
of high scientific quality.
Our appraisal is therefore that evaluation of societal
quality is as important as scientific evaluation: scientific
and societal quality evaluation should be considered to
be synergistic in terms of learning for the future,
accountability and advocacy. The communication meta-
phor is useful to ‘de-ideologise’ the debate, showing that
scientific quality and societal quality can be seen as two
sides of the same coin. The communication metaphor
has also been shown to be a good framework to start
the rather new field of societal evaluation as it runs par-
allel to scientific evaluation.
We conclude from the pilot study that we have taken
t h ef i r s ts t e po nal o n gt r a c kt oi n c o r p o r a t es o c i e t a le x -
post evaluation in addition to scientific ex-post evalua-
tion of health research at the level of research groups. It
has been shown to result in meaningful data that can be
validated internally and externally. The results have
been shown to be stable for small changes in the para-
meters of the counting scheme. It is necessary to con-
tinue these efforts to show the robustness of the
method over time in the LUMC environment (validation
in time), to show its usefulness in other university medi-
cal centre R&D environments in the Netherlands and
abroad (contextual validation).
As a next step, it would be useful to include a normal-
isation of the size of a research group. In this pilot, large
departments (more than 50 researchers) are directly
compared to small departments (less than 20 research-
ers). It could be hypothesised that large groups have a
greater capacity for outreach activities, which are more
beneficial for societal quality than smaller departments.
However, this should be investigated in more detail.
The methodology for societal ex-post evaluation at
research group level is still at quite an early stage com-
pared to the internationally accepted methodology for
scientific evaluation of research groups as developed by
CWTS that all Dutch UMCs adhere to. This method is
based on normalised peer reviewed science citation
impact analysis, which does not include earning capacity
(or research income). Therefore, the order of magnitude
of earning capacity is used as the only external valuation
of the research conducted in the research group. This
income however does not relate directly to any specific
project because the quality is assessed at the level of the
entire research group.
Follow-up research is needed to reduce and pre-define
(and therefore remove the necessity of lumping bottom-
up reported activities) the extensive set of indicators
used in this pilot study to an internationally agreed,
accepted and less laborious set, which would allow for
automation of data collection. The stability of the calcu-
lation scheme suggests that the indicators tend to corre-
late with each other. This in principle opens the way to
reduce the number of indicators.
However, the discussion on metrics and indicators
typical for a quantitative approach, conceals the fact
that this method does involve a qualitative phase as
well. This includes feedback to the research groups,
defining mission and objectives by research groups and
simultaneous activities directed at one or more of the
societal sectors, discussion on weighting factors, and
peer review by external stakeholders in the case of an
external evaluation. Therefore, we do not overestimate
the value of quantifying and calculating with metrics,
but instead seek to maintain a balanced approach. Even
though ‘metrics’ have their place, and can make assess-
ment of societal quality more efficient and cost-effective,
their role is to signal, rather than be a direct replace-
ment for qualitative assessments.
Because of the weighting of indicators, it is possible to
adjust the method to the objectives of a research group.
For example, when a research group’s objective is more
focused on outreach to the private sector, the indicators
for private sector societal quality can be valued as more
important than the indicators for societal quality with
respect to healthcare professionals. The possibility to
adjust the methodology to measure the effects reflecting
the objectives of the research group is of added value.
Ideally, a research group has a mission and objectives as
to what they are aiming for with their research, both in
scientific and in societal terms. But as long as they do
not have explicit societal objectives, activities and out-
puts in this area are hard to adjust. Therefore, demon-
strating the societal quality of medical research, even
without a clear objective, stresses its value. This directly
relates to the purpose of the evaluation, and the com-
missioning entity. Evaluations can be used for:
￿ justification (to produce data that can be used to
justify or promote a programme);
￿ monitoring and measurement (count outputs,
determine the efficiency and productivity of these
outputs relative to the inputs); but also for
￿ learning (to understand what the programme is
actually doing; how it is achieving/not-achieving its
results); or
￿ management and improvement (to use learning
from evaluation process in order to improve the
programme).
In this case, the pilot study has been commissioned by
the Executive Board of the LUMC, because they con-
sider societal quality important on an organisational
level. That being the case, reporting on this tends to be
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ies. The method described above is a means to get a
better understanding of all interactions with society, i.e.
serves a learning purpose. Additionally, the information
from societal quality assessment is ultimately intended
to be used in the regular planning and control cycle of
organisations. This is deemed fair as for some disci-
plines, societal quality is at least as important as scienti-
fic quality or medical production.
H o w e v e r ,t h ep r i n c i p a lp u r p o s eo ft h i sp i l o ts t u d yi s
its contribution to creating awareness of what societal
quality is, and how to make the concept operational, in
a way that is not principally different and/or contradic-
tory to evaluation of scientific quality.
Discussion
The health science and innovation system in the
Netherlands is currently at a unique stage of integration.
All medical faculties are effectively integrated with their
academic hospitals, which resulted in the creation of the
University Medical Centers (UMCs). At the intermediate
level, the research council (ZonMw) is the merger of the
medical department of the Dutch Research Council
(NWO-MW) and the innovation department of the pub-
lic health policy system (the Ministry of Health, Welfare
and Sport). Compared to the UK, ZonMw could be con-
sidered as the merger of the MRC and the R&D depart-
m e n to ft h eN H S .I ti sa g a i n s tt h i sc o n t e x tt h a tt h e
above study may be of value. It is an attempt to evaluate
the societal quality of all health research, basic and
applied. We are convinced that in modern medical and
health sciences the distinction between basic (long-
term) and applied (short-term) research will disappear.
Increasingly basic research has short time practical con-
sequences in the health care system and in privately
owned health companies. Conversely, applied research
and the implementation of established results often
need a long-term approach. The fact that basic and
applied health research systems do not act as an inte-
grated system will be less acceptable to the general pub-
lic. Also, more often the UMCs in the Netherlands
consider the spin-off to the economic system as their
societal obligation. Although this is encouraged by
(Dutch) governmental departments, it is not yet realised
at the intermediary level.
In comparison with other methods that are designed to
measure societal quality, the methodology described here
resembles the Sci_Quest method [36] in that the interac-
tion with surrounding actors in the R&D system is taken
as an important aspect. However, the Sci_Quest method
has been mainly used at an institutional level or pro-
gramme level, and includes other parts of the institu-
tional mission (i.e. education and training) as part of the
evaluation, whereas this model focuses at the research
group level. Interaction and outreach is also measured in
a different way: Sci_Quest reflects on the outputs by peer
review with stakeholders and takes into account their
perception whereas the model described here is limited
to the activities and outputs of the research group itself.
Like the Sci_Quest method, our evaluation methodology
takes a transversal approach. This means that outputs
measured are not necessarily related to the same piece or
programme of research. This is different from the Pay-
back framework [29,30], which takes a longitudinal
approach in time that relates outputs and impacts to the
same piece or programme of research, but not necessarily
to the same actors. The Sci_Quest method and communi-
cation metaphor therefore eventually relate to the impact
of research performers and the Payback framework to the
impact of knowledge generation. As such, the three mod-
els complement rather than contradict each other and
can be used for different levels of aggregation, time hori-
zons and perspectives of research evaluation.
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